ALICIA SLOAN: Open Payments
NPI 1013432251 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 44 payments from 15 companies in 2025. Trend: 2023 $1,320 · 2024 $804 · 2025 $1,068
Food & beverage: $1,049Education: $19
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $253 |
| ABBVIE INC. | 13 | $211 |
| Janssen Scientific Affairs, LLC | 3 | $201 |
| Ardelyx, Inc. | 6 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $31 |
| Madrigal Pharmaceuticals | 1 | $26 |
| Solventum Corporation | 1 | $24 |
| Novo Nordisk Inc | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: TREMFYA, RINVOQ, IBSRELA, ENTYVIO, QULIPTA, JOURNAVX, SKYRIZI, REZDIFFRA.
Industry payments across FL — which companies pay providers there.
